Owens & Minor (OMI) Q3 Earnings and Revenues Top Estimates

Core Viewpoint - Owens & Minor reported quarterly earnings of $0.42 per share, exceeding the Zacks Consensus Estimate of$0.40 per share, but down from $0.44 per share a year ago, indicating a 5$2.72 billion for the quarter ended September 2024, surpassing the Zacks Consensus Estimate by 1.25% and showing an increase from 2.59 billion year-over-year [2] - Over the last four quarters, Owens & Minor has exceeded consensus EPS estimates four times and topped revenue estimates twice [2] Stock Performance - Owens & Minor shares have declined approximately 30.7% since the beginning of the year, contrasting with the S&P 500's gain of 20.1% [3] - The current Zacks Rank for Owens & Minor is 3 (Hold), suggesting the stock is expected to perform in line with the market in the near future [6] Earnings Outlook - The consensus EPS estimate for the upcoming quarter is 0.61 on revenues of $2.74 billion, and for the current fiscal year, it is$1.57 on revenues of $10.71 billion [7] - The trend of estimate revisions for Owens & Minor is currently mixed, which may change following the recent earnings report [6] Industry Context - The Medical - Products industry, to which Owens & Minor belongs, is currently ranked in the top 30% of over 250 Zacks industries, indicating a favorable outlook compared to lower-ranked industries [8]